$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp

2015 Q3 Form 10-Q Financial Statement

#000114420415048760 Filed on August 13, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q2 2014 Q2
Revenue $48.00 $0.00 $303.00
YoY Change -65.47% -100.0% -32.82%
Cost Of Revenue
YoY Change
Gross Profit $303.00
YoY Change -32.82%
Gross Profit Margin 100.0%
Selling, General & Admin $0.00 $20.00K $20.00K
YoY Change -100.0% 0.0% 0.0%
% of Gross Profit 6600.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $6.080K $18.67K $16.32K
YoY Change -2.86% 14.37% 7.06%
Operating Profit -$6.032K -$18.67K -$16.02K
YoY Change -1.44% 16.53% 8.27%
Interest Expense $4.034K $3.655K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$4.034K -$3.655K
YoY Change
Pretax Income -$10.07K -$18.63K -$16.02K
YoY Change 64.48% 16.27% -16.23%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$10.07K -$22.15K -$16.02K
YoY Change 64.48% 38.24% -16.23%
Net Earnings / Revenue -20970.83% -5286.8%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.972K -$3.945K -$3.945K
COMMON SHARES
Basic Shares Outstanding 5.073M shares 5.073M shares 5.073M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $201.00 $371.00 $680.00
YoY Change -66.44% -45.44%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $201.00 $371.00 $680.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $201.00 $371.00 $680.00
YoY Change -66.44% -45.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.102K $8.753K $10.00K
YoY Change -18.98% -12.47%
Accrued Expenses $169.00 $11.70K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $10.00K $10.00K $0.00
YoY Change -50.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.12K $57.49K $20.07K
YoY Change 145.58% 186.41% -33.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $64.12K $57.49K $20.07K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $64.12K $57.49K $20.07K
YoY Change 145.58% 186.41% -33.09%
SHAREHOLDERS EQUITY
Retained Earnings -$161.0K -$150.9K
YoY Change
Common Stock $5.073K $5.073K $5.073K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$63.92K -$57.12K -$19.39K
YoY Change
Total Liabilities & Shareholders Equity $201.00 $371.00 $680.00
YoY Change -66.44% -45.44%

Cashflow Statement

Concept 2015 Q3 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$10.07K -$22.15K -$16.02K
YoY Change 64.48% 38.24% -16.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$20.00K $0.00 $0.00
YoY Change 0.0% -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.00K 0.000 0.000
YoY Change 0.0% -100.0%
NET CHANGE
Cash From Operating Activities -20.00K 0.000 0.000
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 20.00K 0.000 0.000
Net Change In Cash 0.000 0.000 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$20.00K $0.00 $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Income Loss
OperatingIncomeLoss
-28244 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-19917 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-33728 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20247 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Net Income Loss
NetIncomeLoss
-33728 USD
us-gaap Net Income Loss
NetIncomeLoss
-20247 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5073000 shares
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9966 USD
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3000 USD
CY2015Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
43251 USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
22628 USD
CY2015Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
5484 USD
CY2014Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
57488 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35594 USD
CY2015Q2 us-gaap Liabilities
Liabilities
57488 USD
CY2014Q4 us-gaap Liabilities
Liabilities
35594 USD
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2015Q2 us-gaap Cash
Cash
371 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
88723 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76723 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150913 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117185 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-57117 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-35389 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
371 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205 USD
CY2014Q4 us-gaap Cash
Cash
205 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
371 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
205 USD
CY2015Q2 us-gaap Assets
Assets
371 USD
CY2014Q4 us-gaap Assets
Assets
205 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8753 USD
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Operating Expenses
OperatingExpenses
28657 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28657 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20385 USD
us-gaap Operating Expenses
OperatingExpenses
20385 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
3655 USD
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Sales Revenue Net
SalesRevenueNet
413 USD
us-gaap Sales Revenue Net
SalesRevenueNet
468 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
16322 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
USD
us-gaap Interest Expense
InterestExpense
5484 USD
us-gaap Interest Expense
InterestExpense
330 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3655 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5484 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-330 USD
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
300 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
303 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18790 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16322 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18490 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16019 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22145 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16019 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-22145 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-16019 USD
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2013Q4 us-gaap Cash
Cash
525 USD
CY2014Q2 us-gaap Cash
Cash
680 USD
osok Noncash Investing And Financing Items Forgiveness Convertible Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessConvertibleNotesPayableWithAccruedInterestRelatedParty
USD
osok Noncash Investing And Financing Items Forgiveness Convertible Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessConvertibleNotesPayableWithAccruedInterestRelatedParty
6952 USD
us-gaap Accretion Of Discount
AccretionOfDiscount
5484 USD
us-gaap Accretion Of Discount
AccretionOfDiscount
330 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4213 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11702 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-32457 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
155 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
osok Noncash Investing And Financing Items Forgiveness Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessNotesPayableWithAccruedInterestRelatedParty
23242 USD
osok Noncash Investing And Financing Items Forgiveness Accounts Payable Related Party
NoncashInvestingAndFinancingItemsForgivenessAccountsPayableRelatedParty
952 USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
osok Noncash Investing And Financing Items Forgiveness Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessNotesPayableWithAccruedInterestRelatedParty
USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
20623 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
32623 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
166 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
155 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
8370 USD
osok Noncash Investing And Financing Items Forgiveness Accounts Payable Related Party
NoncashInvestingAndFinancingItemsForgivenessAccountsPayableRelatedParty
USD
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2015Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
us-gaap Advertising Expense
AdvertisingExpense
USD
CY2014Q2 us-gaap Advertising Expense
AdvertisingExpense
USD
CY2015Q2 us-gaap Advertising Expense
AdvertisingExpense
USD
us-gaap Use Of Estimates
UseOfEstimates
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="text-decoration: underline;">Use of Estimates</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="text-decoration: underline;">Products and services, geographic areas and major customers</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The company derives revenue from the licensing of songs to the television and music industry. All fee revenues each year were domestic and to external customers.</p> </div>
us-gaap Advertising Expense
AdvertisingExpense
USD
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
22628 USD
CY2014Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
22628 USD
CY2014 osok Adjustments To Additional Paid In Capital Gain On Forgiveness Of Related Party Debt
AdjustmentsToAdditionalPaidInCapitalGainOnForgivenessOfRelatedPartyDebt
952 USD
CY2015Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
43251 USD
CY2014Q4 osok Related Party Forgiveness Of Note Payable Convertible Note Payable And Accrued Interest
RelatedPartyForgivenessOfNotePayableConvertibleNotePayableAndAccruedInterest
28146 USD
CY2015Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
6000 USD
CY2015Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.001
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
12000 USD
osok Number Of Debt Instruments
NumberOfDebtInstruments
2 item
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001500198
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Entity Registrant Name
EntityRegistrantName
Original Source Entertainment, Inc.

Files In Submission

Name View Source Status
0001144204-15-048760-index-headers.html Edgar Link pending
0001144204-15-048760-index.html Edgar Link pending
0001144204-15-048760.txt Edgar Link pending
0001144204-15-048760-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
osok-20150630.xml Edgar Link completed
osok-20150630.xsd Edgar Link pending
osok-20150630_cal.xml Edgar Link unprocessable
osok-20150630_def.xml Edgar Link unprocessable
osok-20150630_lab.xml Edgar Link unprocessable
osok-20150630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v417734_10-q.htm Edgar Link pending
v417734_ex31.htm Edgar Link pending
v417734_ex32.htm Edgar Link pending